Armando R. Irizarry

1.3k total citations
18 papers, 970 citations indexed

About

Armando R. Irizarry is a scholar working on Small Animals, Molecular Biology and Immunology. According to data from OpenAlex, Armando R. Irizarry has authored 18 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Small Animals, 5 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Armando R. Irizarry's work include Immunotoxicology and immune responses (4 papers), Animal testing and alternatives (4 papers) and Clinical Laboratory Practices and Quality Control (2 papers). Armando R. Irizarry is often cited by papers focused on Immunotoxicology and immune responses (4 papers), Animal testing and alternatives (4 papers) and Clinical Laboratory Practices and Quality Control (2 papers). Armando R. Irizarry collaborates with scholars based in United States, France and Russia. Armando R. Irizarry's co-authors include Jane C. Stewart, Michael S. Kinch, Nicole D. Zantek, Daniel P. Zelinski, Barbara C. Hansen, Alexei Kharitonenkov, Jennifer A. Martin, Andrew C. Adams, Sharon R Myers and Vincent L. Reynolds and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Toxicological Sciences.

In The Last Decade

Armando R. Irizarry

18 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Armando R. Irizarry United States 13 503 283 166 147 107 18 970
Shizue Ohsawa Japan 17 736 1.5× 162 0.6× 559 3.4× 130 0.9× 231 2.2× 35 1.5k
E. D. Wachsmuth Switzerland 19 552 1.1× 150 0.5× 106 0.6× 239 1.6× 76 0.7× 65 1.0k
Z Lojda Czechia 17 344 0.7× 205 0.7× 108 0.7× 274 1.9× 52 0.5× 92 988
Gordon Vansant United States 12 618 1.2× 73 0.3× 65 0.4× 106 0.7× 260 2.4× 21 1.1k
Franck Galland France 22 831 1.7× 127 0.4× 152 0.9× 192 1.3× 217 2.0× 42 1.4k
Takuro Ariga Japan 20 770 1.5× 162 0.6× 163 1.0× 96 0.7× 229 2.1× 88 1.6k
Florent Martin France 16 575 1.1× 105 0.4× 132 0.8× 336 2.3× 157 1.5× 38 1.4k
Zhiming Wang China 21 607 1.2× 138 0.5× 37 0.2× 142 1.0× 85 0.8× 65 1.2k
Sanna Lehtonen Finland 26 1.1k 2.1× 63 0.2× 329 2.0× 96 0.7× 181 1.7× 73 1.9k
Long Cheng China 20 728 1.4× 54 0.2× 85 0.5× 147 1.0× 125 1.2× 60 1.2k

Countries citing papers authored by Armando R. Irizarry

Since Specialization
Citations

This map shows the geographic impact of Armando R. Irizarry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armando R. Irizarry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armando R. Irizarry more than expected).

Fields of papers citing papers by Armando R. Irizarry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Armando R. Irizarry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armando R. Irizarry. The network helps show where Armando R. Irizarry may publish in the future.

Co-authorship network of co-authors of Armando R. Irizarry

This figure shows the co-authorship network connecting the top 25 collaborators of Armando R. Irizarry. A scholar is included among the top collaborators of Armando R. Irizarry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Armando R. Irizarry. Armando R. Irizarry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hukkanen, Renee, et al.. (2020). Opinion on Performing Pathology Peer-Review During the Global Pandemic: Challenges and Opportunities. Toxicologic Pathology. 48(8). 944–948. 3 indexed citations
2.
Irizarry, Armando R., Guirui Yan, Qingqiang Zeng, et al.. (2017). Defective enamel and bone development in sodium-dependent citrate transporter (NaCT) Slc13a5 deficient mice. PLoS ONE. 12(4). e0175465–e0175465. 40 indexed citations
3.
Sutherland, Jeffrey J., Yue Webster, Jeffrey A. Willy, et al.. (2017). Toxicogenomic module associations with pathogenesis: a network-based approach to understanding drug toxicity. The Pharmacogenomics Journal. 18(3). 377–390. 64 indexed citations
4.
Irizarry, Armando R., Kathryn E. Gropp, & Darlene Dixon. (2016). A Brief Overview of the STP 35th Annual Symposium on the Basis and Relevance of Variation in Toxicologic Responses. Toxicologic Pathology. 45(1). 52–56. 1 indexed citations
5.
Schultze, A. Eric & Armando R. Irizarry. (2016). Recognizing and Reducing Analytical Errors and Sources of Variation in Clinical Pathology Data in Safety Assessment Studies. Toxicologic Pathology. 45(2). 281–287. 17 indexed citations
6.
Tripathi, Niraj, et al.. (2016). Deciphering Sources of Variability in Clinical Pathology. Toxicologic Pathology. 45(1). 90–93. 3 indexed citations
7.
Adams, Andrew C., Barbara C. Hansen, Armando R. Irizarry, et al.. (2013). LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys. PLoS ONE. 8(6). e65763–e65763. 142 indexed citations
8.
Morton, Daniel, Rani S. Sellers, Erio Barale-Thomas, et al.. (2010). Recommendations for Pathology Peer Review. Toxicologic Pathology. 38(7). 1118–1127. 45 indexed citations
9.
Engle, Steven K., William H. Jordan, Alan Y. Chiang, et al.. (2009). Qualification of Cardiac Troponin I Concentration in Mouse Serum Using Isoproterenol and Implementation in Pharmacology Studies to Accelerate Drug Development. Toxicologic Pathology. 37(5). 617–628. 35 indexed citations
10.
Guo, Yin, Robert A. Jolly, Thomas K. Baker, et al.. (2007). Underlying Mechanisms of Pharmacology and Toxicity of a Novel PPAR Agonist Revealed Using Rodent and Canine Hepatocytes. Toxicological Sciences. 96(2). 294–309. 31 indexed citations
11.
Sloop, Kyle W., Aaron D. Showalter, Amy L. Cox, et al.. (2007). Specific Reduction of Hepatic Glucose 6-Phosphate Transporter-1 Ameliorates Diabetes while Avoiding Complications of Glycogen Storage Disease. Journal of Biological Chemistry. 282(26). 19113–19121. 10 indexed citations
12.
Rudmann, Daniel G., et al.. (2007). The Rat Mammary Gland: Morphologic Changes as an Indicator of Systemic Hormonal Perturbations Induced by Xenobiotics. Toxicologic Pathology. 35(2). 199–207. 51 indexed citations
13.
Allender, Matthew C., Michael M. Fry, Armando R. Irizarry, et al.. (2006). Intracytoplasmic Inclusions in Circulating Leukocytes from an Eastern Box Turtle (Terrapene carolina carolina) with Iridoviral Infection. Journal of Wildlife Diseases. 42(3). 677–684. 57 indexed citations
14.
Logani, Mahendra K., et al.. (2002). Effect of millimeter waves on cyclophosphamide induced suppression of the immune system. Bioelectromagnetics. 23(8). 614–621. 19 indexed citations
15.
Zelinski, Daniel P., Nicole D. Zantek, Jane C. Stewart, Armando R. Irizarry, & Michael S. Kinch. (2001). EphA2 overexpression causes tumorigenesis of mammary epithelial cells.. PubMed. 61(5). 2301–6. 391 indexed citations
16.
Irizarry, Armando R., et al.. (2001). Impression Smear of Liver Tissue from a Rabbit. Veterinary Clinical Pathology. 30(2). 57–61. 15 indexed citations
17.
Facemire, Paul R., Janice E. Sojka, Stephen B. Adams, et al.. (2000). Treatment of granular cell tumor via complete right lung resection in a horse. Journal of the American Veterinary Medical Association. 217(10). 1522–1525. 11 indexed citations
18.
Kiupel, Matti, Peter B. Mueller, Julia Vara, Armando R. Irizarry, & Tiffany Lin. (2000). Multiple Endocrine Neoplasia in a Dog. Journal of Comparative Pathology. 123(2-3). 210–217. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shizue Ohsawa Breakdown of academic impact, for papers by E. D. Wachsmuth Breakdown of academic impact, for papers by Z Lojda Breakdown of academic impact, for papers by Gordon Vansant Breakdown of academic impact, for papers by Franck Galland Breakdown of academic impact, for papers by Takuro Ariga Breakdown of academic impact, for papers by Florent Martin Breakdown of academic impact, for papers by Zhiming Wang Breakdown of academic impact, for papers by Sanna Lehtonen Breakdown of academic impact, for papers by Long Cheng
Rankless by CCL
2026